EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina

Christine D Hsu, Louise M Henderson, Bradford E Jackson, Christopher D Baggett, Michele Johnson Funk, Andrew F Olshan, Parul Gupta, A Sidney Barritt, Hanna K Sanoff, Stephanie B Wheeler, Jennifer L Lund, Andrew M Moon

North Carolina Medical Journal · 2025

DOI: 10.18043/001c.151714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift North Carolina Medical Journal, 2025. Verfasst von Christine D Hsu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis, Early Detection of Cancer. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Clinical guidelines recommend hepatocellular carcinoma (HCC) surveillance with an abdominal ultrasound every 6 months for individuals with cirrhosis. However, surveillance uptake is low, and few studies have examined factors associated with surveillance uptake using large, contemporary cohorts. METHODS Using claims data from Medicare, Medicaid, and private plans in North Carolina, we conducted a retrospective cohort study including individuals aged 18 years old and older with a first claims-based cirrhosis diagnosis between January 1, 2010, and June 30, 2018, with at least 12 months of continuous insurance enrollment before the cirrhosis diagnosis. A subdistribution hazard model was used to assess associations between patient-, provider-, and area-level factors and 2-year cumulative incidence of HCC surveillance. RESULTS Among 46,052 individuals with cirrhosis, 54.7% received a first HCC surveillance exam within 2 years after the cirrhosis diagnosis. Those with non-viral cirrhosis etiologies had lower surveillance uptake than individuals with viral hepatitis. Subdistribution hazard ratios were higher for those with Medicare versus Medicaid, for those with decompensated versus compensated cirrhosis, and for those with gastroenterology/hepatology care in the year before their cirrhosis diagnosis versus those without specialty care. LIMITATIONS Potentially important barriers to HCC surveillance, such as cost- and transportation-related factors, were not included or directly ascertained in the analyses, as they were not available in the claims data. CONCLUSIONS Individuals with non-viral cirrhosis etiologies, Medicare insurance, decompensated cirrhosis, and gastroenterology care in the year before the index date were more likely to receive an HCC surveillance exam in the 2 years after their cirrhosis diagnosis than their counterparts. Findings from this study may serve as a benchmark to measure state-level progress in increasing HCC surveillance and help identify subgroups to target for future interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver CirrhosisEarly Detection of CancerHumansFemaleNorth CarolinaMaleRetrospective StudiesMiddle AgedAgedUnited StatesMedicareMedicaidAdultUltrasonographyIncidence

Stichwörter der Autor:innen

North Carolinacirrhosiscirrhosis diagnosisclinical guidelineshealth policyhepatocellular carcinomamedicalmedical journalmedical surveillance examsoriginal research

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas.
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Department of Radiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Zitieren

APA

Hsu, C. D., Henderson, L. M., Jackson, B. E., Baggett, C. D., Johnson Funk, M., Olshan, A. F., Gupta, P., Barritt, A. S., Sanoff, H. K., Wheeler, S. B., Lund, J. L., & Moon, A. M. (2025). Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina. North Carolina Medical Journal. https://doi.org/10.18043/001c.151714

Vancouver

Hsu CD, Henderson LM, Jackson BE, Baggett CD, Johnson Funk M, Olshan AF, et al. Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina. North Carolina Medical Journal. 2025. doi:10.18043/001c.151714

BibTeX
@article{Hsu2025,
  author = {Hsu, Christine D and Henderson, Louise M and Jackson, Bradford E and Baggett, Christopher D and Johnson Funk, Michele and Olshan, Andrew F and Gupta, Parul and Barritt, A Sidney and Sanoff, Hanna K and Wheeler, Stephanie B and Lund, Jennifer L and Moon, Andrew M},
  title = {Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina},
  journal = {North Carolina Medical Journal},
  year = {2025},
  doi = {10.18043/001c.151714}
}
Kostenlos starten →